Provided by Tiger Trade Technology Pte. Ltd.

Therapeutics

3.58
-0.2100-5.54%
Post-market: 3.670.0900+2.51%19:30 EDT
Volume:1.13M
Turnover:4.07M
Market Cap:112.02M
PE:-0.87
High:3.84
Open:3.84
Low:3.51
Close:3.79
52wk High:50.40
52wk Low:3.51
Shares:31.29M
Float Shares:18.39M
Volume Ratio:1.48
T/O Rate:6.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1300
EPS(LYR):-2.8503
ROE:-59.21%
ROA:-37.36%
PB:0.51
PE(LYR):-1.26

Loading ...

Travere Therapeutics: Buy Rating Reiterated as CEO Transition Seen as Non-Disruptive, $67 Price Target Unchanged

TIPRANKS
·
Sep 22

RBC Raises Price Target on Viridian Therapeutics to $38 From $36, Keeps Outperform, Speculative Risk

MT Newswires Live
·
Sep 22

Travere Therapeutics Price Target Maintained with a $67.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 22

Obsidian Therapeutics initiated with an Outperform at Leerink

TIPRANKS
·
Sep 22

Iambic Therapeutics Files for Nasdaq IPO

MT Newswires Live
·
Sep 22

Chimeric Therapeutics Seeks Quotation for 22.2 Million New Shares on ASX

TIPRANKS
·
Sep 22

Cathie Wood’s ARK Investment buys 103K shares of Beam Therapeutics today

TIPRANKS
·
Sep 22

These Beaten-Down Stocks Could Bounce Back in January, if History is Any Guide

Dow Jones
·
Sep 22

Travere Therapeutics appoints new CEO Bradley Campbell

TIPRANKS
·
Sep 22

AI Drug Discovery Firm Iambic Therapeutics Files for IPO

Dow Jones
·
Sep 22

Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2026 Investor Conference

GlobeNewswire
·
Sep 22

Travere Therapeutics CEO Dube to step down

TIPRANKS
·
Sep 22

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 22

Arcturus Therapeutics management to meet virtually with Cantor

TIPRANKS
·
Sep 22

BlossomHill Therapeutics is Maintained at Outperform by Leerink Partners

Dow Jones
·
Sep 22

TenNor Therapeutics Launches 2026 H Share Incentive Plan and Adjusts Articles

TIPRANKS
·
Sep 21

Cutia Therapeutics Gets Macao Approval for Topical Finasteride Spray

MT Newswires Live
·
Sep 21

Abbisko Therapeutics Posts Encouraging Phase II Data for Pediatric Achondroplasia Drug

TIPRANKS
·
Sep 21

Prescient Therapeutics Requests Trading Halt Ahead of Capital Raising Announcement

TIPRANKS
·
Sep 21

Specialised Therapeutics expands partnership with Incyte to include Opzelura

TIPRANKS
·
Sep 21